Association of probiotics combined with glutamine with postoperative outcomes in children with Hirschsprung disease: a retrospective propensity score-matched cohort study.

IF 2.2 3区 医学 Q2 PEDIATRICS
Frontiers in Pediatrics Pub Date : 2026-10-05 eCollection Date: 2026-01-01 DOI:10.3389/fped.2026.1953553
Peiyu Zhao, Qingqing Wang, Fang Wei, Guoqi Zheng, Shanshan Su
{"title":"Association of probiotics combined with glutamine with postoperative outcomes in children with Hirschsprung disease: a retrospective propensity score-matched cohort study.","authors":"Peiyu Zhao, Qingqing Wang, Fang Wei, Guoqi Zheng, Shanshan Su","doi":"10.3389/fped.2026.1953553","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To evaluate the association between postoperative use of probiotics combined with glutamine and intestinal function recovery, Hirschsprung disease-associated enterocolitis (HAEC), nutritional status, and immune-inflammatory indicators following radical surgery for Hirschsprung disease (HD).</p><p><strong>Methods: </strong>This retrospective observational cohort study included children who underwent radical surgery for HD at our hospital between January 2023 and December 2025. According to the actual postoperative regimen received, patients were divided into an observation group receiving probiotics combined with glutamine in addition to conventional postoperative management (<i>n</i> = 46) and a control group receiving conventional postoperative management alone without the probiotic preparation or glutamine supplementation used in the observation group (<i>n</i> = 48). A 1:1 propensity score matching (PSM) was performed to reduce confounding from measured baseline characteristics and improve covariate balance between the non-randomized treatment groups, resulting in 40 matched pairs. Postoperative recovery of bowel sounds, time to first defecation, length of hospital stay, HAEC incidence at 6 months postoperatively, and changes in nutritional markers (albumin, prealbumin, transferrin), peripheral blood T lymphocyte subsets (CD4⁺, CD4⁺/CD8⁺ ratio), and inflammatory cytokines (IL-10, IL-6) were compared between the two groups.</p><p><strong>Results: </strong>After PSM, the observation group exhibited significantly shorter times for recovery of bowel sounds, first defecation, and hospital stay compared to the control group [(22.5 ± 7.8) h vs. (34.6 ± 9.5) h, (38.5 ± 10.1) h vs. (51.8 ± 12.5) h, (10.5 ± 3.0) d vs. (14.4 ± 4.2) d, all <i>P</i> < 0.001]. At 6 months postoperatively, the incidence of HAEC was lower in the observation group than in the control group [10.0% (4/40) vs. 32.5% (13/40), <i>P</i> = 0.014]. Baseline nutritional, inflammatory, and cellular immune indicators were comparable between the matched groups (all <i>P</i> > 0.05). From baseline to 3 months, the observation group showed greater increases in albumin, prealbumin, transferrin, IL-10, CD4 percentage, and CD4/CD8 ratio and a greater decrease in IL-6 than the control group (all <i>P</i> < 0.001).</p><p><strong>Conclusion: </strong>In this retrospective observational cohort, postoperative use of probiotics combined with glutamine was associated with earlier intestinal function recovery, shorter hospitalization, a lower incidence of HAEC, and more favorable nutritional, cellular immune, and inflammatory indicators after PSM. These findings should be interpreted as associations rather than evidence of a causal treatment effect and require confirmation in prospective randomized studies.</p>","PeriodicalId":12637,"journal":{"name":"Frontiers in Pediatrics","volume":"14 ","pages":"1953553"},"PeriodicalIF":2.2000,"publicationDate":"2026-10-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13677887/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Pediatrics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3389/fped.2026.1953553","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"PEDIATRICS","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: To evaluate the association between postoperative use of probiotics combined with glutamine and intestinal function recovery, Hirschsprung disease-associated enterocolitis (HAEC), nutritional status, and immune-inflammatory indicators following radical surgery for Hirschsprung disease (HD).

Methods: This retrospective observational cohort study included children who underwent radical surgery for HD at our hospital between January 2023 and December 2025. According to the actual postoperative regimen received, patients were divided into an observation group receiving probiotics combined with glutamine in addition to conventional postoperative management (n = 46) and a control group receiving conventional postoperative management alone without the probiotic preparation or glutamine supplementation used in the observation group (n = 48). A 1:1 propensity score matching (PSM) was performed to reduce confounding from measured baseline characteristics and improve covariate balance between the non-randomized treatment groups, resulting in 40 matched pairs. Postoperative recovery of bowel sounds, time to first defecation, length of hospital stay, HAEC incidence at 6 months postoperatively, and changes in nutritional markers (albumin, prealbumin, transferrin), peripheral blood T lymphocyte subsets (CD4⁺, CD4⁺/CD8⁺ ratio), and inflammatory cytokines (IL-10, IL-6) were compared between the two groups.

Results: After PSM, the observation group exhibited significantly shorter times for recovery of bowel sounds, first defecation, and hospital stay compared to the control group [(22.5 ± 7.8) h vs. (34.6 ± 9.5) h, (38.5 ± 10.1) h vs. (51.8 ± 12.5) h, (10.5 ± 3.0) d vs. (14.4 ± 4.2) d, all P < 0.001]. At 6 months postoperatively, the incidence of HAEC was lower in the observation group than in the control group [10.0% (4/40) vs. 32.5% (13/40), P = 0.014]. Baseline nutritional, inflammatory, and cellular immune indicators were comparable between the matched groups (all P > 0.05). From baseline to 3 months, the observation group showed greater increases in albumin, prealbumin, transferrin, IL-10, CD4 percentage, and CD4/CD8 ratio and a greater decrease in IL-6 than the control group (all P < 0.001).

Conclusion: In this retrospective observational cohort, postoperative use of probiotics combined with glutamine was associated with earlier intestinal function recovery, shorter hospitalization, a lower incidence of HAEC, and more favorable nutritional, cellular immune, and inflammatory indicators after PSM. These findings should be interpreted as associations rather than evidence of a causal treatment effect and require confirmation in prospective randomized studies.

益生菌联合谷氨酰胺与先天性巨结肠患儿术后预后的关系:一项回顾性倾向评分匹配队列研究
目的:评价巨结肠病根治性手术后益生菌联合谷氨酰胺与肠道功能恢复、巨结肠病相关小肠结肠炎(HAEC)、营养状况和免疫炎症指标的关系。方法:这项回顾性观察队列研究纳入了2023年1月至2025年12月在我院接受根治性HD手术的儿童。根据患者术后实际接受的治疗方案,将患者分为观察组(n = 46)和对照组(n = 48),观察组在术后常规治疗的基础上给予益生菌联合谷氨酰胺治疗。对照组仅给予术后常规治疗,不给予观察组益生菌制剂和谷氨酰胺补充。采用1:1的倾向评分匹配(PSM)来减少测量基线特征的混淆,并改善非随机治疗组之间的协变量平衡,得到40对匹配。比较两组患者术后肠音恢复情况、首次排便时间、住院时间、术后6个月HAEC发生率、营养指标(白蛋白、白蛋白前体、转铁蛋白)、外周血T淋巴细胞亚群(CD4 +、CD4 + /CD8 +之比)、炎症因子(IL-10、IL-6)的变化。结果:PSM后,观察组恢复肠音、首次排便、住院时间均明显短于对照组[(22.5±7.8)h比(34.6±9.5)h,(38.5±10.1)h比(51.8±12.5)h,(10.5±3.0)d比(14.4±4.2)d, P = 0.014]。基线营养、炎症和细胞免疫指标在匹配组之间具有可比性(均P < 0.05)。从基线到3个月,观察组患者白蛋白、白蛋白前蛋白、转铁蛋白、IL-10、CD4百分比、CD4/CD8比值均显著高于对照组,IL-6显著低于对照组(均P)。在这一回顾性观察队列中,术后使用益生菌联合谷氨酰胺与PSM后更早的肠道功能恢复、更短的住院时间、更低的HAEC发生率以及更有利的营养、细胞免疫和炎症指标相关。这些发现应被解释为关联,而不是因果治疗效果的证据,需要在前瞻性随机研究中得到证实。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Frontiers in Pediatrics
Frontiers in Pediatrics Medicine-Pediatrics, Perinatology and Child Health
CiteScore
3.60
自引率
7.70%
发文量
2132
审稿时长
14 weeks
期刊介绍: Frontiers in Pediatrics (Impact Factor 2.33) publishes rigorously peer-reviewed research broadly across the field, from basic to clinical research that meets ongoing challenges in pediatric patient care and child health. Field Chief Editors Arjan Te Pas at Leiden University and Michael L. Moritz at the Children''s Hospital of Pittsburgh are supported by an outstanding Editorial Board of international experts. This multidisciplinary open-access journal is at the forefront of disseminating and communicating scientific knowledge and impactful discoveries to researchers, academics, clinicians and the public worldwide. Frontiers in Pediatrics also features Research Topics, Frontiers special theme-focused issues managed by Guest Associate Editors, addressing important areas in pediatrics. In this fashion, Frontiers serves as an outlet to publish the broadest aspects of pediatrics in both basic and clinical research, including high-quality reviews, case reports, editorials and commentaries related to all aspects of pediatrics.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书